Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
28 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/28/3068881/0/en/BioVersys-to-Host-Virtual-KOL-Event-to-Discuss-BV100-Phase-2-Ventilator-Associated-Pneumonia-VABP-Study-Against-Carbapenem-Resistant-Acinetobacter-on-May-7-2025.html
08 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/08/3057310/0/en/BioVersys-to-Present-BV100-Phase-2-Data-at-35th-ESCMID-Global-2025.html
26 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/26/3049321/0/en/BioVersys-Reports-Corporate-Highlights-and-Key-Financials-for-the-Full-Year-2024.html
06 Feb 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-02-06/bioversys-successfully-completes-its-ipo-at-chf-36-per-share-and-starts-trading-on-the-six-swiss-exc
22 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/22/2966616/0/en/BioVersys-Joins-EU-Funded-RespiriNTM-Programme-to-Accelerate-Development-of-Its-Broad-Spectrum-Drug-Candidates-Against-NTM-Pulmonary-Diseases.html
16 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/16/2963759/0/en/Bioversys-Announces-Last-Patient-Last-Visit-in-BV100-Phase-2-Clinical-Trial-in-Ventilator-Associated-Bacterial-Pneumonia-VABP-and-Provides-a-Business-Update.html
ABOUT THIS PAGE